[{"id":"bd4617ab-7189-4260-bc25-2d4214ac040d","acronym":"","url":"https://clinicaltrials.gov/study/NCT02926690","created_at":"2021-01-18T14:22:30.547Z","updated_at":"2024-07-02T16:35:57.295Z","phase":"Phase 1","brief_title":"Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer","source_id_and_acronym":"NCT02926690","lead_sponsor":"OncoTherapy Science, Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e OTS167"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 05/29/2017","start_date":" 05/29/2017","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2023-01-20"}]